Beranda › Eksim › California › Los Angeles
Uji klinis Eksim di Los Angeles, CA
5 studi untuk Eksim mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Menerima pesertaFase 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Menerima pesertaFase 2
- Metropolis Dermatology - DTLA, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Inmagene Site 23, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Menerima pesertaFase 2
- California Allergy and Asthma Medical Group, Los Angeles
Uji klinis Eksim di kota lain
- San Antonio, TX7 studi
- Birmingham, AL6 studi
- New York City, NY5 studi
- San Diego, CA5 studi
- Indianapolis, IN5 studi
- Washington, DC4 studi
- Huntington Beach, CA4 studi
- Miami, FL4 studi
- Santa Clarita, CA4 studi
- Pittsburgh, PA4 studi
- Phoenix, AZ4 studi
- San Francisco, CA3 studi
Studi lain di Los Angeles
- Kanker Paru Non-Sel Kecil87 studi
- Kanker (semua jenis)74 studi
- Kanker Payudara73 studi
- Kanker Prostat61 studi
- Kanker Kolorektal59 studi
- Kanker Metastatik57 studi
- Kanker Ovarium50 studi
- Kanker Paru45 studi
- Karsinoma Sel Skuamosa Kepala dan Leher42 studi
- Kanker Pankreas35 studi
- Kanker Endometrium34 studi
- Melanoma34 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.